Ticker
EYPTCompany Name
EYEPOINT PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Operating Margin | Operating Income | Revenues |
---|---|---|---|
6/30/2025 | -364.27% | $ -189.05M | $ 51.9M |
3/31/2025 | -287.94% | $ -161.37M | $ 56.04M |
12/31/2024 | -337.06% | $ -145.85M | $ 43.27M |
9/30/2024 | -255.88% | $ -116.97M | $ 45.71M |
6/30/2024 | -195.71% | $ -98.62M | $ 50.39M |
3/31/2024 | -173.6% | $ -86.83M | $ 50.02M |
12/31/2023 | -163.13% | $ -75.07M | $ 46.02M |
9/30/2023 | -240.92% | $ -102.45M | $ 42.52M |
6/30/2023 | -285.13% | $ -106.45M | $ 37.33M |
3/31/2023 | -258.6% | $ -102.9M | $ 39.79M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Op. Inc. / Revenues
(=) Operating %
Operating % for EYEPOINT PHARMACEUTICALS INC is calculated as follows: Op. Inc. [ $ -33.54M ] / Revenues [ $ 35.94M ]
(=) Operating % [ -93.32% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.27K |
---|---|
min | -71.54% |
max | 83.49% |
average | 9.05% |
median | 8.75% |
std | 23.74% |